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Abstract
Rationale—Three subsets of mitochondria have been described in adult cardiomyocytes - 
intermyofibrillar (IMF), subsarcolemmal (SSM), and perinuclear (PN). They have been shown to 
differ in physiology, but whether they also vary in morphological characteristics is unknown. 
Ischemic preconditioning (IPC) is known to prevent mitochondrial dysfunction induced by acute 
myocardial ischemia/reperfusion injury (IRI), but whether IPC can also modulate mitochondrial 
morphology is not known.
Aims—Morphological characteristics of three different subsets of adult cardiac mitochondria 
along with the effect of ischemia and IPC on mitochondrial morphology will be investigated.
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Methods—Mouse hearts were subjected to the following treatments (N=6 for each group): 
stabilization only, IPC (3x5 min cycles of global ischemia and reperfusion), ischemia only (20 min 
global ischemia); and IPC and ischemia. Hearts were then processed for electron microscopy and 
mitochondrial morphology was assessed subsequently.
Results—In adult cardiomyocytes, IMF mitochondria were found to be more elongated and less 
spherical than PN and SSM mitochondria. PN mitochondria were smaller in size when compared 
to the other two subsets. SSM mitochondria had similar area to IMF mitochondria but their 
sphericity measures were similar to PN mitochondria. Ischemia was shown to increase the 
sphericity parameters of all 3 subsets of mitochondria; reduce the length of IMF mitochondria, and 
increase the size of PN mitochondria. IPC had no effect on mitochondrial morphology either at 
baseline or after ischemia.
Conclusion—The three subsets of mitochondria in the adult heart are morphologically different. 
IPC does not appear to modulate mitochondrial morphology in adult cardiomyocytes.
Keywords
Ischemic preconditioning; intermyofibrillar mitochondria; subsarcolemmal mitochondria; 
perinuclear mitochondria; Ischemic reperfusion injury
INTRODUCTION
There are three distinct sub-populations of mitochondria present in adult cardiomyocytes: 
Intermyofibrillar (IMF) mitochondria, which reside between the myofibers and mainly 
provide energy for myocardial contraction; subsarcolemmal (SSM) mitochondria that are 
localized beneath the plasma membrane and provide energy for ion channel function; and 
perinuclear (PN) mitochondria that are juxtaposed to the cell nucleus and mainly provide 
energy for gene transcription1,2. These 3 mitochondrial subtypes in the heart have been 
shown to differ in function in terms of oxidative capacity, calcium uptake and sensitivity to 
mitochondrial permeability transition (MPTP) opening3–7. In spite of the presence of large 
volume of literature concerning the physiology of cardiac mitochondria, the morphological 
differences between the 3 mitochondrial subtypes have not been comprehensively 
investigated in the adult heart.
Changes in mitochondrial morphology and function have been shown to be critical to the 
susceptibility of the heart to acute ischemia/reperfusion injury (IRI), and the cardioprotective 
phenomenon of ischemic preconditioning (IPC), an intriguing phenomenon in which one or 
more cycles of brief ischemia and reperfusion render the myocardium tolerant to lethal 
IRI8–10. The mechanisms underlying IPC have been extensively investigated and comprise a 
complex array of signal transduction pathways many of which converge on and preserve the 
function of mitochondria following acute IRI. A number of prosurvival kinases implicated in 
IPC signaling such as AKT and PKA have been shown to modulate the mitochondrial 
function11,12. Hence, it is plausible to hypothesize that IPC induces its cardioprotective 
effect by modulating the morphology of cardiac mitochondria.
In this study, we investigate the morphological differences between the three subtypes of 
mitochondria in adult murine cardiomyocytes and investigate the changes induced by 
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ischemia. We then investigate the effect of IPC on mitochondrial morphology at baseline and 
following ischemia.
MATERIALS AND METHODS
Experimental procedures were performed in accordance to the Animals (Scientific 
Procedures) Act 1986 published by the UK Home Office. Hearts obtained from male 8–10 
weeks old C57/BL6 mice were used throughout.
Langendorff
Mouse hearts were extracted after the induction of euthanasia (Sodium Pentobarbitone 
(20mg/ml)) and were cannulated and perfused with Krebs-Henseleit buffer containing NaCl 
(118 mM), NaHCO3 (25 mM), d-Gluocose (11 mM), KCl (4.7 mM), MgSO4.7H2O (1.22 
mM), KH2PO4 (1.21 mM) and CaCl2.H2O (1.84 mM) on a constant pressure Langendorff 
setup gassed with 95% O2-5% CO2, pH 7.35–7.45. Hearts were randomly allocated four 
different treatment groups (N=6 for each group) and were subjected to either:
a. 55 minutes of stabilization (ST)
b. 25 minutes of stabilization and IPC protocol of 3x cycles of 5 minutes 
ischemia/5 minutes reperfusion (ST+IPC)
c. 55 minutes of stabilization and 20 minutes of ischemia (ST+ IS)
d. 25 minutes of stabilization and 30 minutes of IPC followed by 20 minutes of 
ischemia (ST+IPC+IS) as shown in Figure 1.
TEM specimen processing and imaging
Hearts were fixed using EM grade 1% paraformaldehyde, 2% glutaraldehyde in 0.1M 
sodium cacodylate buffer. Sections from left ventricle were obtained from the hearts and 
were post-fixed using 2% osmium tetraoxide for 2 hours at 4°C. Each segment then 
underwent sequential dehydration using different concentration of ethanol (25%, 50%, 70%, 
90%, 100%) and washed with 1,2-epoxypropane, before being embedded in Epoxy resin 
(Poly/Bed-21844-1). Ultrathin sections of 70nm were cut using an ultra-microtome 
(Reichert) and were further stained using lead citrate. Images were acquired using a Jeol 
1010 transmission electron microscopes equipped with Gatan Orius and had a pixel 
dimensions of 5 x 5 nm in both X and Y. For each subtype of mitochondria in each heart, 6 
representative cells in their longitudinal orientation were captured in a blinded fashion. In 
total, 7,301 IMF mitochondria, 5,346 PN mitochondria and 3739 mitochondria were 
segmented and analyzed. Cells with intact fibers were selected for the analysis and 
hypercontracted cells as well as cells with myofibrillar disarray were excluded from the 
analysis.
Image analysis
Three subsets of cardiac mitochondria were segmented and traced using image J (V. 1.47). 
Shape descriptors of individual mitochondria were measured in 2D including:
a. “surface area (expressed as μm2)”;
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b. “perimeter (the distance surrounding the actual shape of mitochondria in 2D, 
expressed in μm)”;
c. “aspect ratio (AR) (representing major to minor axis ratio)”;
d. “Feret’s diameter (defined as the longest distance between any two points within 
the selected mitochondrion, expressed in μm)”;
e. “roundness (calculated by the formula: 4 x Area/π x Major axis2)”; and
f. “circularity (calculated by the formula: 4π x Area/Perimeter2). Mitochondria 
exhibiting a perfect circular shape have a circularity value close to 1.0 whereas 
more elongated mitochondria have a circularity value that is closer to 0.0)”.
Statistics
All statistical tests were performed using Stata (v.13). Mitochondrial shape descriptors were 
analyzed using the mixed effects model with random effects accounting for variability 
among cells and hearts of the nested structure, and the fixed effects of mitochondrial types 
or different treatments. Mitochondrial Area and AR were logarithmically transformed in 
order to perform the analysis on normally distributed data. Graphs illustrating model-
predicted means and 95% confidence intervals were made using Microsoft Excel 2010. Box 
and whiskers plot, illustrating the median and 5% to 95% percentile, were used to show 
frequency distribution of individual shape descriptors. p value of ≤0.05 was considered 
significant.
RESULTS
Morphological Differences of Three Subtypes of Cardiac Mitochondria
The precise location of cardiac mitochondria determines their morphological constitution13. 
In mouse cardiac myocytes IMF mitochondria are often rectangular and are extended 
between the myofibers allowing them to make contact with their two juxtaposed 
mitochondria (indicated by white arrows in Figure 2) whereas SSM mitochondria reside by 
the subsarcolemmal region and form clusters that are less organized than the IMF 
mitochondria (indicated by black arrows in Figure 2).
Similarly, PN mitochondria also form clusters around the nucleus of cardiac myocytes and 
extend between the myofibers but lack the typical elongated morphology of IMF 
mitochondria (indicated by yellow arrow and star in Figure 2).
Morphological comparisons of different subsets at ST indicated that the IMF mitochondria 
are not larger than SSM mitochondria (Figure 3a), however, they have significantly larger 
perimeter (Figure 3b), which corresponds to their rectangular shape and greater Feret’s 
diameter (Figure 3c). These facts are also evident from the distribution of shape descriptors 
of these two individual subtypes (see Supplementary Figure 1).
In addition, the rounder (Figure 3d) and more circular shape (Figure 3e) of SSM 
mitochondria as well as their lower AR (Figure 3f) and perimeter (Figure 3b) makes this 
subtype less elongated than IMF mitochondria. Moreover, PN mitochondria are smaller in 
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respect to area (Figure 3a); shorter in terms of perimeter (Figure 3b) and Feret’s diameter 
(Figure 3c) when compared to the other two mitochondrial subtypes. Lower AR (Figure 3f) 
as well as higher roundness (Figure 3d) and circularity (Figure 3e) also indicates that the 
mitochondria belonging to this subtype are not branched and extended to the other region of 
cardiomyocytes and instead interacts with their neighboring mitochondria thereby permitting 
faster inter-mitochondrial communication (refer to Supplementary Figure 1 for distributions 
of individual subsets). Collectively, these data indicate the presence of three morphologically 
disparate subtypes of mitochondria in adult cardiac mitochondria.
Pronounced alteration in morphology of IMF mitochondria in response to ischemia
IMF mitochondria are known to be less sensitive to ischemia in comparison to SSM 
mitochondria5,14. IPC itself does not have any significant effect on morphology of IMF 
mitochondria (Figures 4a, 4b and 5) and the distribution of their shape descriptors 
(Supplementary Figure 2); however, IPC alters the intermyofibrillar space and the level of 
mitochondrial compactness between the intermyofibrillar regions as shown in Figure 4b. The 
compactness of myofibers is further disrupted upon the induction of ischemia and IPC 
treatment given prior to ischemia does not prevent the occurrence of this alteration (Figure 
4c and 4d). Further, this change is accompanied by a shift in distribution patterns of 
individual mitochondrial shape descriptors shown in Supplementary Figure 2. Ischemia 
induces a dramatic 11% reduction in Feret’s diameter (Figure 5c) and 27% increase in 
roundness of IMF mitochondria (Figure 5d). Although mitochondrial area does not change 
after ischemia (Figure 5a), the presence of significant changes in mitochondrial circularity 
(Figure 5e) and AR (Figure 5f) as well as a non-significant trend towards a decrease in 
mitochondrial perimeter (Figure 5b) further hints to the magnitude of ischemia-induced 
fragmentation in this subtype. Lastly, the absence of significant shape differences between 
the groups which received ischemia with or without IPC, shown in Figure 5, suggests that 
the morphological alterations of IMF mitochondria after ischemia are not preserved by the 
IPC treatment
Shape changes in SSM mitochondria
SSM mitochondria maintain their condensed network after individual treatments while 
losing their elongated morphology (Figure 6). Phenotypic alterations are substantially less 
evident in SSM mitochondria in comparison to IMF after the IPC only treatment (Figure 6a 
and 6b). However, SSM mitochondria receiving ischemia only or IPC before the ischemia 
show an extensive increase in rotundity (See Figure 6c and 6d). In parallel to the data from 
IMF mitochondria, IPC only treatment does not induce any significant changes in shape 
parameters and their distribution in SSM mitochondria (Figure 7 and Supplementary Figure 
3).
Morphometric evaluation of the groups receiving ischemia with or without IPC point to the 
absence of any changes in SSM mitochondria in terms of area and perimeter of all treatment 
groups (Figure 7a, 7b and Supplementary Figure 3). Unlike IMF mitochondria, ischemia 
alone does not change the Feret’s diameter of SSM mitochondria whereas hearts receiving 
IPC before ischemia exhibit a significant reduction of Feret’s diameter (Figure 7c). In 
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addition, no significant differences are observed in terms of Feret’s diameter between groups 
receiving ischemia with or without IPC (Figure 7c).
In line with sphericity data of IMF mitochondria, ischemia alone induces a 13% rise in 
roundness of SSM mitochondria (Figure 7d). This in turn is accompanied by the reduction of 
AR (Figure 7f) and an increase in circularity (Figure 7e) thereby indicating a reduction of 
elongated SSM mitochondria after ischemia. In parallel to the data from IMF mitochondria, 
IPC given prior to ischemia does not induce any meaningful significant changes in respect to 
the morphology of SSM mitochondria after ischemia (Figure 7 & Supplementary Figure 3).
PN mitochondria respond differently to ischemia and IPC
Perinuclear mitochondria are the least studied mitochondria in adult cardiac myocytes. EM 
micrographs of PN mitochondria undergoing IPC-only treatment illustrate an absence of any 
substantial positional and morphological changes (Figure 8a, 8b). In comparison, PN 
mitochondria from the ischemia-only group or ischemia group receiving IPC exhibit larger 
as well as more circular PN mitochondria (Figure 8c and 8d - yellow arrows). Besides, a 
distinct loss of endoplasmic reticulum structure around the nuclear region is evident in these 
ischemic groups (Figure 8c, 8d). PN mitochondria do not exhibit morphological alterations 
after IPC only treatment (Figure 9 and Supplementary 4). In contrast to the morphometric 
data from SSM and IMF, an increase in PN mitochondrial area (Figure 9a) can indicate 
potential swelling of PN mitochondria following ischemia. Besides, IPC treatment given 
prior to ischemia (Figure 9a) does not prevent the significant rise in the area and perimeter 
of this subset (Figure 9a and 9b). Together, with the lack of any significant difference in 
respect to perimeter and Feret’s diameter of the two ischemic groups (Figure 9b and 9c) 
these data indicate the absence of any modulating effect of IPC on PN mitochondria. 
Moreover, the increase in roundness (Figure 9d), circularity (Figure 9f and 9e) and AR 
(Figure 9f) of PN mitochondria additionally demonstrate that the morphological alterations 
induced by ischemia are not altered by IPC (see Supplementary Figure 4 for the distributions 
of individual parameters).
CONCLUSION
In this study, we showed for the first time that the three subsets of mitochondria in the adult 
heart differ in their morphological characteristics and respond differently to ischemic stress. 
We also found that IPC had no effect on mitochondrial morphology at baseline and 
following ischemia. Subtype heterogeneity of cardiac mitochondria in terms of physiology 
and morphology has been described to be critical for the effective response to pathological 
stimuli and is highly preserved in mammals2,15–19. Although the role of mitochondrial 
morphology in cellular physiology has become clearer in recent years, the exact 
morphological behavior of cardiac mitochondria under normal and pathological settings 
have not been comprehensively studied and are For mainly confined to IMF and SSM 
mitochondria13,20–23. Furthermore, the morphological status of mitochondria within cells are 
directly linked with their function24,25 instance, H2O2 insult of neonatal rat ventricular 
myocytes induces a dysregulation of Ca2+ handling and dissipation of mitochondrial 
membrane potential which in turn increases the measure of mitochondrial roundness26. 
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Similarly, IRI simulation in H9C2 cells has been shown to induce the formation of circular 
donut shaped mitochondria which possess lower membrane potential and altered K+ cannel 
activity in comparison to their elongated counterparts which further supports the link 
between the morphology of mitochondria and their function27. Consistent with our findings, 
a study of myocardial cells isolated from the monkey’s heart showed that the perinuclear 
mitochondria are the least elongated and most spherical subtype of mitochondria present in 
cardiac myocytes. Interestingly, the same group also showed that the SSM mitochondria are 
longer in diameter than the other subtypes of mitochondria whereas our study showed a 
greater diameter in IMF mitochondria in comparison to other subtypes18. The shape 
differences that we observed between SSM and IMF mitochondria of cardiac myocytes are 
also present in the same subtypes in mouse skeletal muscle cells. Skeletal muscle SSM 
mitochondria are shorter in respect to perimeter and Feret’s diameter as well as being 
rounder in comparison to IMF mitochondria. However, both SSM and IMF mitochondria 
from skeletal muscle mitochondria are shorter in respect to Feret’s diameter and perimeter 
compared with the same subtypes of cardiac mitochondria17. Collectively, these studies 
stress that the shape differences observed in different subtypes of cardiac mitochondria are 
influenced by their regional location. Moreover, the presence of differences in terms of 
shape parameters of same subtypes of mitochondria further emphasizes on the extent of 
species and cell-specific nature of mitochondrial morphology.
The unique metabolic and potential structural differences between various subtypes of 
cardiac mitochondria appear to mediate subtype-specific feedback in response to IRI as well 
as cardioprotective strategies conducted against this insult including IPC. For instance, an 
induction of global no-flow ischemia in rabbit hearts can hamper SSM oxidative 
phosphorylation whereas the IMF mitochondria remains unaffected28. Isolated SSM 
mitochondria from male Sprague Dawley rats also exhibit lower oxidative phosphorylation 
and reduced NADH oxidation after a 40 minutes hypoxia/reoxygenation insult thereby 
indicating the unique properties of mitochondrial subtypes21. Likewise and in partial 
agreement with our data, myocardial infarction via left coronary artery ligation of male 
Sprague Dawley rats has been shown to specifically alter the topography29. In parallel, IPC 
has been shown to induce its cardioprotective effects by increasing the S-nitrosylation, 
promoting the complex I respiration and preserving the activity of electron transport chain 
enzymes of SSM mitochondria30,31. These results indicate the importance of both 
morphology and physiology of different mitochondrial subtypes in cardiomyocytes function.
Major impairment of mitochondrial structure begins before the induction of reperfusion and 
during ischemia and preserving the abrupt fragmentation has been shown to confer 
cardioprotection32–35. Nevertheless, the mechanism behind morphological alterations of 
different subtypes of cardiac mitochondria following acute ischemia is poorly understood. In 
line with previous reports, we observed granulation and increase in mitochondrial roundness 
in all subtypes of mitochondria; however, only PN mitochondria showed significant swelling 
after ischemia36,37.
Our results are consistent with our previous report where we showed a decrease in the length 
of IMF mitochondria after treating mouse hearts with 20 minutes of ischemia34.
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Within the same report we also showed that the mitochondria division inhibitor can preserve 
the morphology of IMF mitochondria thereby indicating the therapeutic potential of 
manipulating this subtype of cardiac mitochondria34. Moreover, preservation of 
mitochondrial morphology via IPC has been previously shown to confer cardioprotection in 
the setting of IRI11,38–40. Although IPC has been suggested to preserve the function of SSM 
mitochondria following IR, we did not observe any IPC-induced preservation of SSM 
mitochondria morphology following ischemia-only treatment30,31. The absence of shape-
preservation in all subtypes of cardiac mitochondria in our study may indicate that the 
possible protective effects of IPC on mitochondrial morphology are not mediated during 
ischemia, but are actually initiated at the start of reperfusion.
In conclusion, we show for the first time that the three subsets of cardiac mitochondria have 
unique shape parameters. Ischemia induced morphological alterations in all three subsets of 
cardiac mitochondria and its effects were not rescued by IPC.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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IMF Intermyofibrillar mitochondria
SSM Subsarcolemmal mitochondria
PN Perinuclear mitochondria
TEM Transmitted electron microscopy
IPC Ischemic preconditioning
MPTP Mitochondrial permeability transition pore
ST Stabilization
EM Electron microscopy
AR Aspect ratio
S.E Standard error
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• There are three subsets of cardiac mitochondria with unique shape parameters
• Ischemia induced morphological alterations in all three subsets of cardiac 
mitochondria
• Ischemic preconditioning does not rescue their phenotype after ischemia
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Figure 1. Experimental protocol
for exploring the effect of ST, ST+IPC, ST+IS and ST+IPC+IS on mitochondrial 
morphology. Times elapsed in minutes are shown above the bars.
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Figure 2. Three different subtypes of cardiac mitochondria
White arrows indicate the IMF mitochondria whereas the yellow and black arrows show the 
PN and SSM mitochondria, respectively. The yellow star indicates the extent of spread of 
PN mitochondria along the myofibers.
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Figure 3. Morphological differences between subtypes of cardiac mitochondria
(a), (b) and (c) represent area, perimeter and Feret’s diameter of different subtypes of 
mitochondria whereas (d), (e) and (f) show roundness, circularity and AR of individual 
mitochondria subtypes, respectively. *** denotes p<0.0001 for subsets compared to IMF 
mitochondria and $$$ denotes p<0.0001 for the comparison of PN vs. SSM mitochondria 
(n=6 for each group).
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Figure 4. Changes of IMF mitochondria after different treatments
(a) and (b) show the ST only or ST with IPC whereas (c) and (d) show the hearts treated 
with ischemia in the absence or presence of IPC, respectively.
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Figure 5. Morphological shape descriptors of IMF mitochondria after different treatments
(a), (b) and (c) represent area, perimeter and Feret’s diameter of different subtypes of 
mitochondria whereas (d), (e) and (f) show roundness, circularity and AR of IMF subtype, 
respectively. * & *** denote p<0.05 and p<0.0001 for treatment compared to ST, 
respectively (ST = stabilization; IPC = ischemic preconditioning; IS = ischemia/n=6 for each 
group).
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Figure 6. Morphological response of SSM mitochondria to different treatments
(a) and (b) images show the ST in the absence or presence of IPC whereas (c) and (d) show 
the hearts treated with ischemia or with IPC prior to ischemia, respectively.
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Figure 7. Alteration of SSM shape parameters after different treatments
(a), (b) and (c) graphs represent area, perimeter and Feret’s diameter of SSM mitochondria 
whereas (d), (e) and (f) show roundness, circularity and AR of SSM mitochondria, 
respectively. * & *** denote p<0.05 and p<0.0001 for treatment compared to ST, 
respectively (ST = stabilization; IPC = ischemic preconditioning; IS = ischemia/n=6 for each 
group).
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Figure 8. Alteration of PN mitochondria according to treatments
Panel (a) depicts ST and panel (b) depicts ST+ IPC. Panels (c) and (d) depict images from 
ischemia only or IPC + ischemia treatments, respectively. Yellow arrows indicate large 
globular PN mitochondria.
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Figure 9. Shape parameter differences of PN mitochondria according to treatment groups
(a), (b) and (c) graphs represent area, perimeter and Feret’s diameter of SSM mitochondria 
whereas (d), (e) and (f) show roundness, circularity and AR of PN mitochondria after 
different treatments, respectively. *, ** & *** denote p<0.05, p<0.001 and p<0.0001 for 
treatment compared to ST, respectively (ST = stabilization; IPC = ischemic preconditioning; 
IS = ischemia/n=6 for each group).
Kalkhoran et al. Page 21
Discoveries (Craiova). Author manuscript; available in PMC 2017 July 20.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Kalkhoran et al. Page 22
Ta
bl
e 
1
Co
m
pa
ris
on
 o
f p
re
di
ct
ed
 m
ea
n 
va
lu
es
 ±
 S
.E
 o
f d
iff
er
en
t s
ha
pe
 d
es
cr
ip
to
rs
 o
f I
nt
er
m
yo
fib
ril
la
r (
IM
F)
, S
ub
sar
co
lem
ma
l (
SS
M
) a
nd
 Pe
rin
uc
lea
r (
PN
) 
m
ito
ch
on
dr
ia
 a
t b
as
el
in
e 
(* 
an
d *
**
 de
no
te 
p≤
0.0
5 a
nd
 p<
0.0
00
1, 
res
pe
cti
v
el
y).
M
ito
ch
on
dr
ia
 S
ub
ty
pe
Lo
g.
 
A
re
a
Pe
ri
m
et
er
Fe
re
t’
s D
ia
m
et
er
Lo
g.
 
A
R
C
irc
u
la
ri
ty
R
ou
nd
ne
ss
IM
F
v
s.
SS
M
5.
78
±0
.3
2
v
s.
5.
77
±0
.3
3
40
20
.4
1±
17
4.
37
v
s.
35
28
.5
9±
18
0.
59
**
*
16
48
.7
0±
75
.2
5
v
s.
13
50
.6
7±
77
.9
1*
**
0.
41
±0
.0
2
v
s.
0.
26
±0
.0
2*
**
0.
64
±0
.0
2
v
s.
0.
75
±0
.0
2*
**
0.
44
±0
.0
2
v
s.
0.
58
±0
.0
2*
**
IM
F
v
s. PN
5.
78
±0
.3
2
v
s.
5.
59
±0
.3
2*
**
40
20
.4
1±
17
4.
37
v
s.
27
93
.2
1±
17
7.
22
**
*
16
48
.7
0±
75
.2
5
v
s.
10
84
.1
0±
76
.4
7*
**
0.
41
±0
.0
2
v
s.
0.
26
±0
.0
2*
**
0.
64
±0
.0
2
v
s.
0.
77
±0
.0
2 
**
*
0.
44
±0
.0
2
v
s.
0.
58
±0
.0
2 
**
*
SS
M
v
s. PN
5.
77
±0
.3
3
v
s.
5.
59
±0
.3
2*
**
35
28
.5
9±
18
0.
59
v
s.
27
93
.2
2±
17
7.
22
**
*
13
50
.6
7±
77
.9
1
v
s.
10
84
.1
0±
76
.4
7*
**
0.
26
±0
.0
2
v
s.
0.
26
±0
.0
2
0.
75
±0
.0
2
v
s.
0.
77
±0
.0
2*
0.
58
±0
.0
2
v
s.
0.
58
±0
.0
2
Discoveries (Craiova). Author manuscript; available in PMC 2017 July 20.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Kalkhoran et al. Page 23
Ta
bl
e 
2
Pa
irw
ise
 c
om
pa
ris
on
 o
f p
re
di
ct
ed
 m
ea
n 
va
lu
es
 ±
 S
.E
 o
f d
iff
er
en
t s
ha
pe
 d
es
cr
ip
to
rs
 o
f I
M
F 
m
ito
ch
on
dr
ia
 a
fte
r i
nd
iv
id
ua
l t
re
at
m
en
ts 
(* 
an
d *
**
 de
no
te 
p≤
0.
05
 an
d 
p<
0.
00
01
, r
es
pe
ct
iv
el
y).
Sp
ec
ifi
c 
Pa
ir
w
ise
 A
na
ly
sis
Pr
ed
ic
te
d 
M
ea
n 
± 
S.
E 
fo
r 
D
iff
er
en
t S
ha
pe
 D
es
cr
ip
to
rs
 o
f I
M
F 
M
ito
ch
on
dr
ia
 a
fte
r D
iff
er
en
t T
re
a
tm
en
ts
Lo
g.
 
A
re
a
Pe
ri
m
et
er
Fe
re
t’
s D
ia
m
et
er
Lo
g.
A
R
C
irc
u
la
ri
ty
R
ou
nd
ne
ss
(S
T)
v
s.
(S
T 
+ I
PC
)
5.
78
±0
.0
2
v
s.
5.
74
±0
.0
2
40
10
.2
4±
14
8.
94
v
s.
37
10
.9
7±
14
7.
96
16
45
.0
8±
69
.8
0
v
s.
15
07
.1
8±
69
.4
0.
41
±0
.0
2
v
s.
0.
37
±0
.0
2
0.
64
±0
.0
2
v
s.
0.
67
±0
.0
2
0.
44
±0
.0
2
v
s.
0.
47
±0
.0
2
(S
T)
v
s.
(S
T 
+ I
S)
5.
78
±0
.0
2
v
s.
5.
85
±0
.0
2
40
10
.2
4±
14
8.
94
v
s.
37
57
.4
0±
14
8.
6
16
45
.0
8±
69
.8
0
v
s.
14
51
.3
3±
69
.6
6*
0.
41
±0
.0
2
v
s.
0.
25
±0
.0
2*
**
0.
64
±0
.0
2
v
s.
0.
78
±0
.0
2*
**
0.
44
±0
.0
2
v
s.
0.
60
±0
.0
2*
(S
T)
v
s.
(S
T 
+ I
PC
+I
S)
5.
78
±0
.0
2
v
s.
5.
83
±0
.0
2
40
10
.2
4±
14
8.
94
v
s.
36
47
.8
9±
14
8.
41
16
45
.0
8±
69
.8
0
v
s.
13
91
.6
2±
69
.5
8*
0.
41
±0
.0
2
v
s.
0.
23
±0
.0
2*
**
0.
64
±0
.0
2
v
s.
0.
80
±0
.0
2*
**
0.
44
±0
.0
2
v
s.
0.
63
±0
.0
2*
(S
T 
+ I
S)
v
s.
(S
T+
 IP
C+
 IS
)
5.
85
±0
.0
2
v
s.
5.
83
±0
.0
2
37
57
.4
0±
14
8.
60
v
s.
36
47
.8
9±
14
8.
41
14
51
.3
3±
69
.6
6
v
s.
13
91
.6
2±
69
.5
8
0.
25
±0
.0
2
v
s.
0.
23
±0
.0
2
0.
80
±0
.0
2
v
s.
0.
80
±0
.0
2
0.
60
±0
.0
2
v
s.
0.
63
±0
.0
2
Discoveries (Craiova). Author manuscript; available in PMC 2017 July 20.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Kalkhoran et al. Page 24
Ta
bl
e 
3
Pa
irw
ise
 c
om
pa
ris
on
 o
f p
re
di
ct
ed
 m
ea
n 
va
lu
es
 ±
 S
.E
 o
f d
iff
er
en
t s
ha
pe
 d
es
cr
ip
to
rs
 o
f S
SM
 m
ito
ch
on
dr
ia
 a
fte
r i
nd
iv
id
ua
l t
re
at
m
en
ts 
(* 
an
d *
**
 de
no
te 
p≤
0.
05
 an
d 
p<
0.
00
01
, r
es
pe
ct
iv
el
y).
Sp
ec
ifi
c 
Pa
ir
w
ise
 A
na
ly
sis
Pr
ed
ic
te
d 
M
ea
n 
± 
S.
E 
fo
r 
D
iff
er
en
t S
ha
pe
 D
es
cr
ip
to
rs
 o
f S
SM
 M
ito
ch
on
dr
ia
 a
fte
r D
iff
er
en
t T
re
a
tm
en
ts
Lo
g.
 
A
re
a
Pe
ri
m
et
er
Fe
re
t’
s D
ia
m
et
er
Lo
g.
A
R
C
irc
u
la
ri
ty
R
ou
nd
ne
ss
(S
T) Vs
.
(S
T 
+ I
PC
)
5.
77
±0
.0
2
v
s.
5.
74
±0
.0
2
35
20
.9
2±
10
0.
08
v
s.
32
92
.3
6±
98
.8
2
13
48
.9
4±
41
.3
7
v
s.
12
54
.7
5±
40
.9
1
0.
26
±0
.0
1
v
s.
0.
25
±0
.0
1
0.
75
±0
.0
1
v
s.
0.
77
±0
.0
1
0.
58
±0
.0
2
v
s.
0.
59
±0
.0
2
(S
T) Vs
.
(S
T 
+ I
S)
5.
77
±0
.0
2
v
s.
5.
83
±0
.0
2
35
20
.9
2±
10
0.
08
v
s.
34
95
.6
8±
99
.4
8
13
48
.9
4±
41
.3
7
v
s.
12
95
.9
0±
41
.1
6
0.
26
±0
.0
1
v
s.
0.
20
±0
.0
1 
**
*
0.
75
±0
.0
1
v
s.
0.
82
±0
.0
1*
**
0.
58
±0
.0
2
v
s.
0.
67
±0
.0
2*
**
(S
T) Vs
.
(S
T 
+ I
PC
+I
S)
5.
77
±0
.0
2
v
s.
5.
77
±0
.0
2
35
20
.9
2±
10
0.
08
v
s.
32
89
.5
0±
98
.5
0
13
48
.9
4 
± 
41
.3
7
v
s.
12
15
.0
7±
 4
0.
80
*
0.
26
±0
.0
1
v
s.
0.
19
±0
.0
1 
**
*
0.
75
±0
.0
1
v
s.
0.
82
±0
.0
1*
**
0.
58
±0
.0
2
v
s.
0.
67
±0
.0
2*
**
(S
T 
+ I
S)
V
s.
(S
T+
 IP
C+
 IS
)
5.
83
±0
.0
2
v
s.
5.
77
±0
.0
2
34
95
.6
8±
99
.4
8 
vs
. 3
28
9.
50
±9
8.
50
12
95
.9
0±
41
.1
6
v
s.
12
15
.0
7±
 4
0.
80
0.
19
±0
.0
1
v
s.
0.
19
±0
.0
1
0.
82
±0
.0
1
v
s.
0.
82
±0
.0
1
0.
67
±0
.0
2
v
s.
0.
67
±0
.0
2
Discoveries (Craiova). Author manuscript; available in PMC 2017 July 20.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Kalkhoran et al. Page 25
Ta
bl
e 
4
Pa
irw
ise
 c
om
pa
ris
on
 o
f p
re
di
ct
ed
 m
ea
n 
va
lu
es
 ±
 S
.E
 o
f d
iff
er
en
t s
ha
pe
 d
es
cr
ip
to
rs
 o
f P
N
 m
ito
ch
on
dr
ia
 a
fte
r i
nd
iv
id
ua
l t
re
at
m
en
ts 
(*,
 **
 an
d*
**
 de
no
te 
p≤
0.
05
, p
<0
.0
01
 an
d 
p<
0.
00
01
, r
es
pe
ct
iv
el
y).
Sp
ec
ifi
c 
Pa
ir
w
ise
 A
na
ly
sis
Pr
ed
ic
te
d 
M
ea
n 
± 
S.
E 
fo
r 
D
iff
er
en
t S
ha
pe
 D
es
cr
ip
to
rs
 o
f P
N
 M
ito
ch
on
dr
ia
 a
fte
r D
iff
er
en
t T
re
a
tm
en
ts
Lo
g.
 
A
re
a
Pe
ri
m
et
er
Fe
re
t’
s D
ia
m
et
er
Lo
g.
A
R
C
irc
u
la
ri
ty
R
ou
nd
ne
ss
(S
T) Vs
.
(S
T 
+ I
PC
)
5.
59
±0
.0
3
v
s.
5.
62
±0
.0
3
27
80
.0
2±
87
.7
6
v
s.
27
83
.0
1±
87
.2
7
10
78
.8
6±
35
.8
9
v
s.
10
62
.3
7±
35
.7
0
0.
26
±0
.0
1
v
s.
0.
23
±0
.0
1
0.
77
±0
.0
1
v
s.
0.
80
±0
.0
1
0.
58
±0
.0
1
V
s.
0.
61
±0
.0
1
(S
T) Vs
.
(S
T 
+ I
S)
5.
59
±0
.0
3
v
s.
5.
69
±0
.0
3 
*
27
80
.0
2±
87
.7
5
v
s.
29
20
.7
2±
88
.4
7
10
78
.8
6±
35
.9
0
v
s.
10
84
.4
1±
36
.1
6
0.
26
±0
.0
1
v
s.
0.
18
±0
.0
1 
**
*
0.
77
±0
.0
1
v
s.
0.
84
±0
.0
1*
**
0.
58
±0
.0
1
V
s.
0.
68
±0
.0
1*
**
(S
T) Vs
.
(S
T 
+ I
PC
+I
S)
5.
59
±0
.0
3
v
s.
5.
71
±0
.0
3 
**
27
80
.0
2±
87
.7
5
v
s.
30
55
.4
2±
86
.9
5 
*
10
78
.8
6±
35
.9
0
v
s.
11
31
.4
7±
 3
5.
58
 *
0.
26
±0
.0
1
v
s.
0.
19
±0
.0
1 
**
*
0.
77
±0
.0
1
v
s.
0.
83
±0
.0
1*
**
0.
58
±0
.0
1
v
s.
0.
68
±0
.0
1*
**
(S
T 
+ I
S)
V
s.
(S
T+
 IP
C+
 IS
)
5.
69
±0
.0
3
v
s.
5.
71
±0
.0
3
29
20
.7
2±
88
.4
7
v
s.
30
55
.4
2±
86
.9
5
10
84
.4
1±
36
.1
6
v
s.
11
31
.4
7 
± 
35
.5
8
0.
18
±0
.0
1
v
s.
0.
19
±0
.0
1
0.
84
±0
.0
1
v
s.
0.
83
±0
.0
1
0.
68
±0
.0
1
V
s.
0.
68
±0
.0
1
Discoveries (Craiova). Author manuscript; available in PMC 2017 July 20.
